Voyager Therapeutics (VYGR) Non-Current Assets (2014 - 2026)

Voyager Therapeutics has disclosed Non-Current Assets across 13 years of filings, most recently posting $72.5 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 23.02% year-over-year to $72.5 million; the TTM figure through Jun 2026 stood at $263.2 million (down 29.08% YoY), while the FY2025 annual figure was $49.6 million, down 57.34% from the prior year.
• Non-Current Assets came in at $72.5 million for Q2 2026 at Voyager Therapeutics, roughly flat from $72.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $116.2 million in Q4 2024 to a low of $31.6 million in Q4 2023.
• Average Non-Current Assets over 5 years is $57.9 million, with a median of $53.1 million recorded in 2022.
• Year-over-year, Non-Current Assets surged 267.89% in 2024 and tumbled 57.34% in 2025.
• Over 5 years, Non-Current Assets stood at $34.9 million in 2022, then declined by 9.35% to $31.6 million in 2023, then surged by 267.89% to $116.2 million in 2024, then plunged by 57.34% to $49.6 million in 2025, then soared by 46.24% to $72.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $72.5 million in Q2 2026, $72.3 million in Q1 2026, and $49.6 million in Q4 2025.